AVAV, the Arlington, Virginia-based defense technology company best known for its Switchblade loitering munitions, uncrewed aircraft systems, and counter-UAS platforms, saw its shares pull back sharply on Monday. The stock declined approximately 3.93% to $183.39, down from the prior session's close of $190.89. The move marks a pause in what had been a blistering rally, as investors lock in profits following last week's extraordinary run and digest a fresh securities fraud class action filing tied to legacy contract issues.
The most straightforward explanation for Monday's decline is simple gravity. AVAV shares had rocketed higher by roughly 38% over the prior week, driven by two powerful catalysts. On June 30, the company reported fiscal fourth-quarter results that crushed Wall Street expectations, with revenue of $641.6 million surging 133% year-over-year and adjusted earnings per share of $1.84 handily beating the $1.47 consensus estimate. Days later, the U.S. Army awarded AeroVironment a $500 million firm-fixed-price contract for counter-unmanned aerial systems, cementing the company's position in one of the Pentagon's highest-priority mission areas. After a move of that magnitude in such a compressed timeframe, a period of consolidation and profit-taking is a natural market dynamic, particularly with the stock still trading more than 50% below its 52-week high near $418.
Adding to the selling pressure, a securities fraud class action lawsuit was announced on Monday by Bleichmar Fonti & Auld LLP on behalf of AeroVironment investors. The complaint alleges that the company and certain senior executives made materially misleading statements regarding the SCAR (Satellite Communication Augmentation Resource) contract with the U.S. Space Force. The SCAR program has been a persistent overhang on AVAV shares since January 2026, when a stop-work order was issued on the BADGER phased-array antenna delivery agreement. The contract was ultimately terminated for convenience, and the Space Force shifted to a multi-vendor acquisition strategy. The lawsuit, which carries a lead plaintiff deadline of July 27, 2026, also references the company's June 22 disclosure that prior financial statements required restatement due to an $89.4 million understatement of operational losses tied to a goodwill impairment on the SCAR program. While securities class actions of this nature typically take years to resolve, the renewed legal headlines are weighing on sentiment.
The decline in AVAV shares on Monday also coincided with broader weakness across the aerospace and defense sector. Peers in the unmanned systems and defense technology space traded lower, reflecting a risk-off tone to start the trading week. Trading volume in AeroVironment was elevated relative to the daily average, indicating conviction behind the move. From a technical perspective, the stock remains well below both its 50-day and 200-day moving averages despite last week's surge, and short interest continues to represent a significant portion of the available float. The stock's inability to hold above the $190 level suggests that resistance near the psychologically important $200 mark remains formidable.
In volatile market environments like the one currently facing defense stocks, traders often turn to data-driven tools to help navigate the turbulence. Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers. These bots vary by strategy, timeframe, and performance metrics, but only the strongest performers under current market conditions are featured in this dynamic section. Whether markets are trending or choppy, the platform provides traders with real-time signals and automated analysis to support more informed decision-making. Explore the Trending AI Robots page to see which strategies are currently leading the pack.
The next major catalyst for AVAV is the company's Investor Day, scheduled for July 8 in New York City. Management is expected to provide a detailed update on its autonomous systems strategy, the integration of the BlueHalo and Empirical Systems Aerospace acquisitions, and the long-term growth trajectory for its counter-UAS business. Investors will be listening closely for any updates on the SCAR recompete process, the remediation plan for the material weakness in internal controls, and whether the $1.2 billion funded backlog can continue converting into revenue at the pace suggested by last week's results. Key risks include further contract disruptions, adverse legal developments from the securities class action, and the possibility that elevated capital expenditures—guided at 12% to 14% of revenue for fiscal 2027—keep free cash flow negative in the near term. With the stock still trading at roughly 54 times the midpoint of management's fiscal 2027 adjusted earnings guidance, execution will need to be nearly flawless to sustain upward momentum.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for AVAV moved out of oversold territory on June 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on July 01, 2026. You may want to consider a long position or call options on AVAV as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AVAV just turned positive on July 01, 2026. Looking at past instances where AVAV's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
AVAV moved above its 50-day moving average on July 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for AVAV crossed bearishly below the 50-day moving average on June 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AVAV broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AVAV entered a downward trend on July 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.792) is normal, around the industry mean (10.983). P/E Ratio (149.026) is within average values for comparable stocks, (95.202). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.106). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (4.098) is also within normal values, averaging (37.825).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of unmanned aircraft and charging systems
Industry AerospaceDefense